Endocrinology Test
|
|
| 1. In toxic adenoma the 1st line treatment is: |
|
|
| 2. Zona reticularis: |
|
|
| 3. The confirmatory marker of Graves’ disease is: |
|
|
| 4. The GH systemic effect is mediated by: |
|
|
| 5. The typical diagnostic trade for Men 2A syndrome is: |
|
|
| 6. OXT is produced secondary to: |
|
|
| 7. In primary hyperaldosteronism: |
|
|
| 8. In hyperparathyroidism the diagnostic steps include: |
|
|
| 9. The following are true regarding fine needle aspiration for thyroid nodules: |
|
|
| 10. Triggers for hypertensive crises in pheocromocytoma are: |
|
|
| 11. Subclinical hyperparathyroidism has to be considered in the following situations: |
|
|
| 12. Antiresorptive agents used as osteoporosis treatment are represented by: |
|
|
| 13. In males LH has the following roles: |
|
|
| 14. The physiologic effects of cortisol are represented by: |
|
|
| 15. Morphofunctional imagistic test for adrenal tumors are: |
|
|
| 16. The clinical suggestive features for thyroid malignancy are: |
|
|
| 17. Laboratory tests for positive diagnosis in pheocromocytoma can reveal: |
|
|
| 18. In the diagnostic of secondary hypothyroidism: |
|
|
| 19. In subacute thyroiditis: |
|
|
| 20. Immunological evaluation of thyroid diseases comprise: |
|
|
| 21. The following are true regarding nodular thyroid disease: |
|
|
| 22. The control mechanisms of arginine vasopressin release include: |
|
|
| 23. In primary hyperaldosteronism: |
|
|
| 24. The clinical picture in chronic primary adrenal insufficiency includes: |
|
|
| 25. The treatment in diffuse goiter is represented by: |
|